Sponsor or institution
Clinical trials and research at PAQ Therapeutics, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by PAQ Therapeutics, Inc. that are recruiting, at sites in 2 countries (most in South Korea (2), United States (2)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
PT0511 for advanced solid tumors with KRAS mutations or amplifications
This trial tests whether the drug PT0511, given alone or with cetuximab for colorectal cancer, is safe and tolerable in adults with advanced solid tumors that have KRAS mutations or KRAS amplification.
-
Evaluating PT0253 for advanced solid tumors with KRAS G12D mutation
This study is testing a new drug called PT0253 to see if it is safe and how well it works for adults with advanced solid tumors that have a specific KRAS G12D mutation.
Quick answers
How many clinical trials run by PAQ Therapeutics, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in South Korea (2 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.